Lazard Asset Management
LOXO

Lazard Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Lazard Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,545
Closed -$788K – 1138
2018
Q2 		$788K Hold
4,545
– – ﹤0.01% 748
2018
Q1 		$524K Buy
4,545
+702
+18% +$74.7K ﹤0.01% 770
2017
Q4 		$323K Buy
+3,843
New +$320K ﹤0.01% 831

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Lazard Asset Management's LOXO Position: Q3 2018 in Review

Lazard Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q3 2018, closing a stake of 4,545 shares — an estimated $788K sold.

Lazard Asset Management first reported a position in LOXO in Q4 2017 and held it in 3 quarters. The position peaked at $788K in Q2 2018. 228 funds tracked by Wall St. Rank hold LOXO as of Q3 2018.

  • Lazard Asset Management reported no remaining Loxo Oncology, Inc position as of Q3 2018 after selling out during the quarter.
  • Lazard Asset Management sold 4,545 Loxo Oncology, Inc shares in Q3 2018, an estimated $788K.
  • Lazard Asset Management first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 3 quarters.
  • Lazard Asset Management's Loxo Oncology, Inc position peaked at $788K in Q2 2018.
  • 228 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2018.

Based on Lazard Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.